Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS
Trial details
- Registry ID
- NCT05349721
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALSNCT05349721 | PTC Therapeutics | Phase 2 | Terminated | 2024-09-26Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |